Targeted Killing of TNFR2-expressing Tumor Cells and Tregs by TNFR2 Antagonistic Antibodies in Advanced Sézary Syndrome

Leukemia - United Kingdom
doi 10.1038/s41375-018-0292-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

TNFR2 and Regulatory T Cells: Potential Immune Checkpoint Target in Cancer Immunotherapy

2019English

TNFR2 Limits Proinflammatory Astrocyte Functions During EAE Induced by Pathogenic DR2b-restricted T Cells

JCI insight
Medicine
2019English

Mechanisms of Sex Differences in TNFR2-Mediated Cardioprotection

Circulation
Cardiovascular MedicinePhysiologyCardiology
2008English

A TNFR2-Agonist Facilitates High Purity Expansion of Human Low Purity Treg Cells

PLoS ONE
Multidisciplinary
2016English

Reduction of TNFR2 Expression in Brain Endothelial Cells in Cerebral Malaria Mice Models After Hyperbaric Oxygen Exposure

International Journal of Innovative Technology and Exploring Engineering
Mechanics of MaterialsElectronic EngineeringCivilStructural EngineeringElectricalComputer Science
2020English

Enhanced Targeting and Killing of Tumor Cells Expressing the CXC Chemokine Receptor 4 by Transducible Anticancer Peptides

Cancer Research
Cancer ResearchOncology
2005English

Erratum: Corrigendum: TNFR2 Expression by CD4 Effector T Cells Is Required to Induce Full-Fledged Experimental Colitis

Scientific Reports
Multidisciplinary
2016English

Targeted Killing of Cultured Cells by Receptor-Dependent Photosensitization.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1981English

Killing the Tumor Cells by Meghamite Nanoparticles

International Journal for Research in Applied Science and Engineering Technology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy